NEUP Neuphoria Therapeutics Inc.

NASDAQ
$2.78

Neuphoria Therapeutics Inc. (NEUP) Institutional Ownership

What the institutions did with NEUP last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended September 30, 2026.

Managers compared
5
filed both this quarter and last
Managers holding
2
-2 on the quarter
Buyers
2
1 opened new
Sellers
3
3 sold out entirely
Buyer share
40.0%
of managers who traded it
Breadth
-20.0
net buyers, as a share of those trading

Only 5 managers reported a position this quarter, so the percentages above describe a very small sample.

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
GEODE CAPITAL MANAGEMENT, LLC 50.6K 100.0%
BARCLAYS PLC 3 0.0%

Largest changes

Manager Action Previous Current Change
FNY Investment Advisers, LLC Sold Out 26.5K 0 -26.5K
COMMONWEALTH EQUITY SERVICES, LLC Sold Out 11.2K 0 -11.2K
GEODE CAPITAL MANAGEMENT, LLC Increased 49.5K 50.6K +1.1K
BARCLAYS PLC New 0 3 +3
Caitong International Asset Management Co., Ltd Sold Out 3 0 -3

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.